Antiretroviral-associated Hepatotoxicity.
The use of highly active antiretroviral therapy has dramatically reduced HIV-associated morbidity and mortality. As a result, patients are often being treated longer and with more complex medical regimens than ever before, increasing the risk for drug interactions and toxicities. In particular, hepatotoxicity caused by antiretroviral use has become an increasingly appreciated potential complication of drug treatment. All classes of antiretrovirals have been reported to induce liver enzyme abnormalities. However, certain antiretrovirals appear much more likely to be associated with drug-induced hepatotoxicity. The risk of antiretroviral-related hepatotoxicity may be associated with patient-specific risk factors, including pre-existing viral hepatitis, baseline elevated liver function test results, female gender, and substance abuse. In addition, complex drug-drug interactions may potentate the risk of antiretroviral-associated hepatotoxicity. Coinfection with hepatitis B or hepatitis C appears to increase the risk of antiretroviral-related hepatotoxicity.
Kress
Kendra D
KD
Roche Laboratories Inc., 340 Kingsland Street, Nutley, NJ 07110, USA. kendra.kress@roche.com.
AIDS. 2005 Jan 3;19(1):97-9
15627041
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S104-8
14986282
AIDS Res Hum Retroviruses. 2004 Jul;20(7):716-22
15307917
N Engl J Med. 1998 Mar 26;338(13):853-60
9516219
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S65-72
14986277
J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):120-5
14722442
Semin Liver Dis. 2003 May;23(2):183-94
12800071
Eur J Clin Pharmacol. 2004 Jul;60(5):343-8
15156302
Semin Liver Dis. 2003 May;23(2):167-72
12800069
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S49-55
14986275
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S56-64
14986276
J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):772-6
15213559
Clin Infect Dis. 2001 Feb 1;32(3):492-7
11170959
Clin Infect Dis. 2004 Aug 1;39(3):402-10
15307009
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S90-7
14986280
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S109-13
14986283
AIDS. 2004 Mar 26;18(5):767-74
15075511
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S73-9
14986278
AIDS. 2004 Nov 19;18(17):2277-84
15577540
Clin Liver Dis. 2003 May;7(2):475-99
12879995
J Acquir Immune Defic Syndr. 2003 Sep;34 Suppl 1:S34-9
14562856
AIDS. 2004 Nov 19;18(17):2221-34
15577534
J Acquir Immune Defic Syndr. 2003 Jun 1;33(2):146-52
12794546
J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):492-502
15021314
Semin Liver Dis. 2003 May;23(2):173-82
12800070
Ann Intern Med. 2002 Mar 19;136(6):480-3
11900502
J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):259-67
12626885
Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S80-9
14986279